Consolidated Statements Of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net income	$ 4,830,000	$ 1,719,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	324,000	331,000
Net amortization of loans and investment securities	124,000	340,000
Amortization of subordinate debt issuance costs	10,000
(Recovery of) provision for loan losses	(800,000)	3,000,000
(Increase) decrease in fair value of equity securities	(54,000)	127,000
Debt securities losses, net		10,000
Loans originated for sale	(28,992,000)	(9,223,000)
Proceeds from sale of loans	34,521,000	8,656,000
Gain on sale of loans	(782,000)	(144,000)
Increase in cash surrender value of life insurance	(115,000)	(124,000)
Gain from surrender of life insurance policy		(812,000)
Stock option compensation	48,000	31,000
Decrease (increase) in other assets	668,000	(1,139,000)
Increae (decrease) in other liabilities	667,000	(281,000)
Net cash provided by operating activities	10,449,000	2,491,000
Cash flows from investing activities
Net decrease (increase) in long-term interest-bearing deposits in other banks	1,746,000	(1,992,000)
Proceeds from sales and calls of investment securities available for sale		165,000
Proceeds from maturities and pay-downs of securities available for sale	9,367,000	10,941,000
Purchase of investment securities available for sale	(45,827,000)	(29,974,000)
Net decrease (increase) in loans	9,439,000	(2,077,000)
Capital expenditures	(168,000)	(174,000)
Net cash used in investing activities	(25,443,000)	(23,111,000)
Cash flows from financing activities
Net increase (decrease) in demand deposits, interest-bearing checking, and savings accounts	69,285,000	(2,452,000)
Net decrease in time deposits	(2,816,000)	(5,507,000)
Dividends paid	(1,318,000)	(1,306,000)
Purchase of Treasury shares	(13,000)	(1,172,000)
Cash received from option exercises	7,000	19,000
Treasury shares issued under dividend reinvestment plan	325,000	560,000
Net cash provided by (used in) financing activities	65,470,000	(9,858,000)
Increase (decrease) in cash and cash equivalents	50,476,000	(30,478,000)
Cash and cash equivalents at the beginning of the period	57,146,000	83,828,000
Cash and cash equivalents at the end of the period	107,622,000	53,350,000
Supplemental Disclosures of Cash Flow Information
Cash paid during the year for: Interest on deposits and other borrowed funds	$ 513,000	1,547,000
Noncash Activities
Lease liabilities arising from obtaining right-of-use assets		105,000
Life insurance claim receivable		$ 3,613,000